Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: January 2, 2026, 8:53 pm
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 504067 | NSE: ZENSARTECH

Zensar Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: January 2, 2026, 8:53 pm

Market Cap 15,917 Cr.
Current Price 699
High / Low 985/536
Stock P/E22.7
Book Value 188
Dividend Yield1.86 %
ROCE21.3 %
ROE16.4 %
Face Value 2.00
PEG Ratio2.09

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Zensar Technologies Ltd

Competitors

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
IDream Film Infrastructure Company Ltd 3.55 Cr. 236 236/98.4 3020.00 %%% 10.0
I Power Solutions India Ltd 13.2 Cr. 22.3 22.3/15.1 11.00.00 %11.6 %16.9 % 10.0
Hypersoft Technologies Ltd 105 Cr. 64.8 101/17.651.6 9.970.00 %20.6 %9.07 % 10.0
Euphoria Infotech (India) Ltd 11.6 Cr. 39.8 64.9/33.17.81 58.70.00 %16.2 %11.5 % 10.0
AccelerateBS India Ltd 26.8 Cr. 78.0 165/67.018.2 15.01.28 %22.2 %17.6 % 10.0
Industry Average124,002.19 Cr842.9447.12158.220.75%20.61%18.63%7.00

All Competitor Stocks of Zensar Technologies Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 1,2351,1981,2131,2271,2411,2041,2301,2881,3081,3261,3591,3851,421
Expenses 1,1291,0631,0379971,0109961,0271,0921,1071,1191,1461,1741,201
Operating Profit 105135176230231208203196201207212211220
OPM % 9%11%14%19%19%17%17%15%15%16%16%15%15%
Other Income 28262728364252424131465749
Interest 8866663444544
Depreciation 49503542373124253024242325
Profit before tax 77104162210225212229210208210230241240
Tax % 26%26%26%26%23%24%24%25%25%24%23%24%24%
Net Profit 5776119156174162173158156160176182182
EPS in Rs 2.513.385.276.907.687.147.656.976.867.047.778.018.01

Last Updated: December 28, 2025, 12:03 pm

Below is a detailed analysis of the quarterly data for Zensar Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Sales, as of Sep 2025, the value is 1,421.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,385.00 Cr. (Jun 2025) to 1,421.00 Cr., marking an increase of 36.00 Cr..
  • For Expenses, as of Sep 2025, the value is 1,201.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,174.00 Cr. (Jun 2025) to 1,201.00 Cr., marking an increase of 27.00 Cr..
  • For Operating Profit, as of Sep 2025, the value is 220.00 Cr.. The value appears strong and on an upward trend. It has increased from 211.00 Cr. (Jun 2025) to 220.00 Cr., marking an increase of 9.00 Cr..
  • For OPM %, as of Sep 2025, the value is 15.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 15.00%.
  • For Other Income, as of Sep 2025, the value is 49.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Jun 2025) to 49.00 Cr., marking a decrease of 8.00 Cr..
  • For Interest, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 4.00 Cr..
  • For Depreciation, as of Sep 2025, the value is 25.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 23.00 Cr. (Jun 2025) to 25.00 Cr., marking an increase of 2.00 Cr..
  • For Profit before tax, as of Sep 2025, the value is 240.00 Cr.. The value appears to be declining and may need further review. It has decreased from 241.00 Cr. (Jun 2025) to 240.00 Cr., marking a decrease of 1.00 Cr..
  • For Tax %, as of Sep 2025, the value is 24.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 24.00%.
  • For Net Profit, as of Sep 2025, the value is 182.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 182.00 Cr..
  • For EPS in Rs, as of Sep 2025, the value is 8.01. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 8.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 4:22 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 2,3352,6562,9523,0563,1083,9664,1823,7814,2444,8484,9025,2815,491
Expenses 1,9772,2642,5132,6742,7433,4873,6893,0973,5874,2964,0304,4644,641
Operating Profit 358392439382365479493685656552872817850
OPM % 15%15%15%12%12%12%12%18%15%11%18%15%15%
Other Income 30275424749388-24138103159160182
Interest 1011119233761543528211716
Depreciation 38426549658915917518518313410296
Profit before tax 340366417349352445362433574444876858921
Tax % 30%28%30%32%30%28%25%29%27%26%24%24%
Net Profit 238265292238246319272307422328665650700
EPS in Rs 10.8611.9412.9710.4710.7413.9311.6913.3018.4014.4729.3428.6130.83
Dividend Payout % 18%18%18%23%22%20%24%27%27%35%31%45%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)11.34%10.19%-18.49%3.36%29.67%-14.73%12.87%37.46%-22.27%102.74%-2.26%
Change in YoY Net Profit Growth (%)0.00%-1.16%-28.68%21.85%26.31%-44.41%27.60%24.59%-59.73%125.02%-105.00%

Zensar Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:5%
3 Years:8%
TTM:8%
Compounded Profit Growth
10 Years:9%
5 Years:20%
3 Years:15%
TTM:1%
Stock Price CAGR
10 Years:17%
5 Years:35%
3 Years:50%
1 Year:-2%
Return on Equity
10 Years:16%
5 Years:16%
3 Years:16%
Last Year:16%

Last Updated: September 5, 2025, 1:56 pm

Balance Sheet

Last Updated: December 10, 2025, 3:40 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 44444545454545454545454546
Reserves 9021,1131,2201,4271,6241,8972,0452,2972,6422,9313,5174,0244,234
Borrowings 1701761491349300332350335273186125117
Other Liabilities 3704024555006188471,1747428178728999781,016
Total Liabilities 1,4861,7341,8692,1062,2963,0903,5963,4333,8404,1214,6485,1735,412
Fixed Assets 4225473864475929501,3231,1331,2541,1741,0341,1701,184
CWIP 212361211010516
Investments 149941342432751152785173248991,4081,7141,594
Other Assets 9141,0921,3471,4131,4242,0131,9831,7832,2602,0492,2002,2882,628
Total Assets 1,4861,7341,8692,1062,2963,0903,5963,4333,8404,1214,6485,1735,412

Below is a detailed analysis of the balance sheet data for Zensar Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 1.00 Cr..
  • For Reserves, as of Sep 2025, the value is 4,234.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,024.00 Cr. (Mar 2025) to 4,234.00 Cr., marking an increase of 210.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 117.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 125.00 Cr. (Mar 2025) to 117.00 Cr., marking a decrease of 8.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 1,016.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 978.00 Cr. (Mar 2025) to 1,016.00 Cr., marking an increase of 38.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 5,412.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,173.00 Cr. (Mar 2025) to 5,412.00 Cr., marking an increase of 239.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 1,184.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,170.00 Cr. (Mar 2025) to 1,184.00 Cr., marking an increase of 14.00 Cr..
  • For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 5.00 Cr..
  • For Investments, as of Sep 2025, the value is 1,594.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,714.00 Cr. (Mar 2025) to 1,594.00 Cr., marking a decrease of 120.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 2,628.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,288.00 Cr. (Mar 2025) to 2,628.00 Cr., marking an increase of 340.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 5,412.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,173.00 Cr. (Mar 2025) to 5,412.00 Cr., marking an increase of 239.00 Cr..

Notably, the Reserves (4,234.00 Cr.) exceed the Borrowings (117.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +209321255304206156686858336714642565
Cash from Investing Activity +-128-182-41-204-142-229-315-5303-527-476-473
Cash from Financing Activity +-77-87-129-50-204201-197-467-183-219-197-264
Net Cash Flow4518550-140128175-139156-31-31-172

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow188.00216.00290.00248.00356.00179.00161.00335.00321.00279.00686.00692.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days566267647581585769555555
Inventory Days272266304
Days Payable300283400
Cash Conversion Cycle2845-29647581585769555555
Working Capital Days444156497057201936212730
ROCE %34%30%31%24%23%23%17%21%21%15%25%21%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters49.15%49.21%49.21%49.20%49.20%49.18%49.17%49.14%49.10%49.07%49.06%49.03%
FIIs10.75%10.53%12.59%16.66%17.12%16.53%15.74%14.84%15.06%14.98%14.56%13.30%
DIIs11.45%15.77%17.30%16.55%16.45%17.53%19.04%19.05%19.83%19.89%20.52%22.24%
Public28.63%24.48%20.89%17.59%17.23%16.77%16.06%16.98%16.01%16.06%15.85%15.43%
No. of Shareholders2,24,5112,11,7541,97,8262,17,6992,25,6572,16,9352,01,7772,17,2182,03,5922,25,5022,10,0632,01,872

Shareholding Pattern Chart

No. of Shareholders

Zensar Technologies Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Hybrid Equity Fund 5,578,744 1.69 418.21N/AN/AN/A
HDFC Small Cap Fund 5,557,056 1.1 416.585,244,6162025-12-15 01:16:265.96%
Franklin India Small Cap Fund 3,374,581 1.87 252.983,220,3402025-12-15 01:16:264.79%
Nippon India Small Cap Fund 2,496,604 0.27 187.164,039,1762025-05-25 10:25:42-38.19%
HSBC Value Fund 2,406,069 1.24 180.372,508,9112025-12-15 01:16:26-4.1%
Invesco India Smallcap Fund 1,672,012 1.39 125.34N/AN/AN/A
Tata Digital India Fund 1,601,303 0.99 120.041,965,1232025-05-25 10:25:42-18.51%
HDFC Childrens Fund 1,521,492 1.07 114.06N/AN/AN/A
ICICI Prudential Technology Fund 1,462,872 0.7 109.661,451,9102025-12-15 01:16:260.76%
HDFC Multi Cap Fund 1,442,563 0.54 108.141,070,1742025-12-15 01:16:2634.8%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 28.6529.3614.4718.4313.31
Diluted EPS (Rs.) 28.4329.1314.4018.2713.18
Cash EPS (Rs.) 33.1135.2722.5426.8421.35
Book Value[Excl.RevalReserv]/Share (Rs.) 179.28157.26131.40118.89105.10
Book Value[Incl.RevalReserv]/Share (Rs.) 179.28157.26131.40118.89105.10
Revenue From Operations / Share (Rs.) 232.63216.42214.05187.78167.61
PBDIT / Share (Rs.) 43.0445.5028.9235.1431.48
PBIT / Share (Rs.) 38.5539.5920.8426.9623.74
PBT / Share (Rs.) 37.7838.6719.6125.4019.19
Net Profit / Share (Rs.) 28.6329.3614.4618.6613.61
NP After MI And SOA / Share (Rs.) 28.6329.3614.4618.4213.30
PBDIT Margin (%) 18.4921.0213.5118.7118.78
PBIT Margin (%) 16.5718.299.7314.3514.16
PBT Margin (%) 16.2417.869.1613.5211.44
Net Profit Margin (%) 12.3013.566.759.938.11
NP After MI And SOA Margin (%) 12.3013.566.759.807.93
Return on Networth / Equity (%) 15.9618.6611.0015.4912.80
Return on Capital Employeed (%) 20.3923.6314.4620.0319.87
Return On Assets (%) 12.5614.307.9410.758.73
Long Term Debt / Equity (X) 0.000.000.000.080.00
Total Debt / Equity (X) 0.000.000.000.080.00
Asset Turnover Ratio (%) 1.081.121.210.540.46
Current Ratio (X) 3.763.042.702.732.70
Quick Ratio (X) 3.763.042.702.732.70
Dividend Payout Ratio (NP) (%) 31.4018.7334.5521.169.01
Dividend Payout Ratio (CP) (%) 27.1515.5922.1614.655.69
Earning Retention Ratio (%) 68.6081.2765.4578.8490.99
Cash Earning Retention Ratio (%) 72.8584.4177.8485.3594.31
Interest Coverage Ratio (X) 56.4749.3123.4822.5013.27
Interest Coverage Ratio (Post Tax) (X) 38.5632.8212.7412.957.65
Enterprise Value (Cr.) 15171.3712988.215476.977684.405517.20
EV / Net Operating Revenue (X) 2.872.651.131.811.46
EV / EBITDA (X) 15.5312.608.369.687.77
MarketCap / Net Operating Revenue (X) 3.012.801.281.961.64
Retention Ratios (%) 68.5981.2665.4478.8390.98
Price / BV (X) 3.913.852.083.092.64
Price / Net Operating Revenue (X) 3.012.801.281.961.64
EarningsYield 0.040.040.050.050.04

After reviewing the key financial ratios for Zensar Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 28.65. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.65, marking a decrease of 0.71.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 28.43. This value is within the healthy range. It has decreased from 29.13 (Mar 24) to 28.43, marking a decrease of 0.70.
  • For Cash EPS (Rs.), as of Mar 25, the value is 33.11. This value is within the healthy range. It has decreased from 35.27 (Mar 24) to 33.11, marking a decrease of 2.16.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.28. It has increased from 157.26 (Mar 24) to 179.28, marking an increase of 22.02.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.28. It has increased from 157.26 (Mar 24) to 179.28, marking an increase of 22.02.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 232.63. It has increased from 216.42 (Mar 24) to 232.63, marking an increase of 16.21.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 43.04. This value is within the healthy range. It has decreased from 45.50 (Mar 24) to 43.04, marking a decrease of 2.46.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 38.55. This value is within the healthy range. It has decreased from 39.59 (Mar 24) to 38.55, marking a decrease of 1.04.
  • For PBT / Share (Rs.), as of Mar 25, the value is 37.78. This value is within the healthy range. It has decreased from 38.67 (Mar 24) to 37.78, marking a decrease of 0.89.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 28.63. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.63, marking a decrease of 0.73.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 28.63. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.63, marking a decrease of 0.73.
  • For PBDIT Margin (%), as of Mar 25, the value is 18.49. This value is within the healthy range. It has decreased from 21.02 (Mar 24) to 18.49, marking a decrease of 2.53.
  • For PBIT Margin (%), as of Mar 25, the value is 16.57. This value is within the healthy range. It has decreased from 18.29 (Mar 24) to 16.57, marking a decrease of 1.72.
  • For PBT Margin (%), as of Mar 25, the value is 16.24. This value is within the healthy range. It has decreased from 17.86 (Mar 24) to 16.24, marking a decrease of 1.62.
  • For Net Profit Margin (%), as of Mar 25, the value is 12.30. This value exceeds the healthy maximum of 10. It has decreased from 13.56 (Mar 24) to 12.30, marking a decrease of 1.26.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.30. This value is within the healthy range. It has decreased from 13.56 (Mar 24) to 12.30, marking a decrease of 1.26.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 15.96. This value is within the healthy range. It has decreased from 18.66 (Mar 24) to 15.96, marking a decrease of 2.70.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has decreased from 23.63 (Mar 24) to 20.39, marking a decrease of 3.24.
  • For Return On Assets (%), as of Mar 25, the value is 12.56. This value is within the healthy range. It has decreased from 14.30 (Mar 24) to 12.56, marking a decrease of 1.74.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.08. It has decreased from 1.12 (Mar 24) to 1.08, marking a decrease of 0.04.
  • For Current Ratio (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 3. It has increased from 3.04 (Mar 24) to 3.76, marking an increase of 0.72.
  • For Quick Ratio (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 2. It has increased from 3.04 (Mar 24) to 3.76, marking an increase of 0.72.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.40. This value is within the healthy range. It has increased from 18.73 (Mar 24) to 31.40, marking an increase of 12.67.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 27.15. This value is within the healthy range. It has increased from 15.59 (Mar 24) to 27.15, marking an increase of 11.56.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 68.60. This value is within the healthy range. It has decreased from 81.27 (Mar 24) to 68.60, marking a decrease of 12.67.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 72.85. This value exceeds the healthy maximum of 70. It has decreased from 84.41 (Mar 24) to 72.85, marking a decrease of 11.56.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 56.47. This value is within the healthy range. It has increased from 49.31 (Mar 24) to 56.47, marking an increase of 7.16.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 38.56. This value is within the healthy range. It has increased from 32.82 (Mar 24) to 38.56, marking an increase of 5.74.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 15,171.37. It has increased from 12,988.21 (Mar 24) to 15,171.37, marking an increase of 2,183.16.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 2.87, marking an increase of 0.22.
  • For EV / EBITDA (X), as of Mar 25, the value is 15.53. This value exceeds the healthy maximum of 15. It has increased from 12.60 (Mar 24) to 15.53, marking an increase of 2.93.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 24) to 3.01, marking an increase of 0.21.
  • For Retention Ratios (%), as of Mar 25, the value is 68.59. This value is within the healthy range. It has decreased from 81.26 (Mar 24) to 68.59, marking a decrease of 12.67.
  • For Price / BV (X), as of Mar 25, the value is 3.91. This value exceeds the healthy maximum of 3. It has increased from 3.85 (Mar 24) to 3.91, marking an increase of 0.06.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 24) to 3.01, marking an increase of 0.21.
  • For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Zensar Technologies Ltd as of January 2, 2026 is: ₹570.32

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of January 2, 2026, Zensar Technologies Ltd is Overvalued by 18.41% compared to the current share price ₹699.00

Intrinsic Value of Zensar Technologies Ltd as of January 2, 2026 is: ₹632.34

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of January 2, 2026, Zensar Technologies Ltd is Overvalued by 9.54% compared to the current share price ₹699.00

Last 5 Year EPS CAGR: 10.87%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 23.75%, which is a positive sign.
  2. The company has higher reserves (2,297.92 cr) compared to borrowings (204.31 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (3.38 cr) and profit (518.23 cr) over the years.
  1. The stock has a high average Working Capital Days of 39.17, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 51.08, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zensar Technologies Ltd:
    1. Net Profit Margin: 12.3%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 20.39% (Industry Average ROCE: 20.61%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 15.96% (Industry Average ROE: 18.63%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 38.56
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 3.76
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 22.7 (Industry average Stock P/E: 47.12)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Zensar Technologies Ltd. is a Public Limited Listed company incorporated on 29/03/1963 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L72200PN1963PLC012621 and registration number is 012621. Currently Company is involved in the business activities of Providing software support and maintenance to the clients. Company's Total Operating Revenue is Rs. 2226.10 Cr. and Equity Capital is Rs. 45.40 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
IT Consulting & SoftwareZensar Knowledge Park, Plot # 4, MIDC Kharadi, Pune Maharashtra 411014Contact not found
Management
NamePosition Held
Mr. H V GoenkaChairman & Non-Exe.Director
Mr. Anant Vardhan GoenkaVice Chairman & Non Exe.Dire
Mr. Manish TandonManaging Director & CEO
Mr. Ketan DalalInd. Non-Executive Director
Mr. Ben DruskinInd. Non-Executive Director
Ms. Radha RajappaInd. Non-Executive Director
Mr. U B Pravin RaoInd. Non-Executive Director
Mr. Harsh MariwalaInd. Non-Executive Director

FAQ

What is the intrinsic value of Zensar Technologies Ltd?

Zensar Technologies Ltd's intrinsic value (as of 02 January 2026) is ₹570.32 which is 18.41% lower the current market price of ₹699.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹15,917 Cr. market cap, FY2025-2026 high/low of ₹985/536, reserves of ₹4,234 Cr, and liabilities of ₹5,412 Cr.

What is the Market Cap of Zensar Technologies Ltd?

The Market Cap of Zensar Technologies Ltd is 15,917 Cr..

What is the current Stock Price of Zensar Technologies Ltd as on 02 January 2026?

The current stock price of Zensar Technologies Ltd as on 02 January 2026 is ₹699.

What is the High / Low of Zensar Technologies Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Zensar Technologies Ltd stocks is ₹985/536.

What is the Stock P/E of Zensar Technologies Ltd?

The Stock P/E of Zensar Technologies Ltd is 22.7.

What is the Book Value of Zensar Technologies Ltd?

The Book Value of Zensar Technologies Ltd is 188.

What is the Dividend Yield of Zensar Technologies Ltd?

The Dividend Yield of Zensar Technologies Ltd is 1.86 %.

What is the ROCE of Zensar Technologies Ltd?

The ROCE of Zensar Technologies Ltd is 21.3 %.

What is the ROE of Zensar Technologies Ltd?

The ROE of Zensar Technologies Ltd is 16.4 %.

What is the Face Value of Zensar Technologies Ltd?

The Face Value of Zensar Technologies Ltd is 2.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Zensar Technologies Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE